The potential of fluorescein-based Smartprobe targeted imaging in lung cancer has also been demonstrated by targeting EGFR mutations in cell line xenograft mouse model34 and this approach has been demonstrated in vivo for urological conditions35 and oesophageal malignancy36. The gene discussed is EGFR; the disease is lung cancer.